IL116826A - Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity - Google Patents

Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity

Info

Publication number
IL116826A
IL116826A IL11682696A IL11682696A IL116826A IL 116826 A IL116826 A IL 116826A IL 11682696 A IL11682696 A IL 11682696A IL 11682696 A IL11682696 A IL 11682696A IL 116826 A IL116826 A IL 116826A
Authority
IL
Israel
Prior art keywords
prophylaxis
obesity
preparation
treatment
pharmaceutical compositions
Prior art date
Application number
IL11682696A
Other languages
English (en)
Other versions
IL116826A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL116826A0 publication Critical patent/IL116826A0/xx
Publication of IL116826A publication Critical patent/IL116826A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11682696A 1995-01-20 1996-01-19 Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity IL116826A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK6695 1995-01-20
DK77495 1995-06-30

Publications (2)

Publication Number Publication Date
IL116826A0 IL116826A0 (en) 1996-05-14
IL116826A true IL116826A (en) 1999-11-30

Family

ID=26063228

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11682696A IL116826A (en) 1995-01-20 1996-01-19 Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity

Country Status (14)

Country Link
US (1) US6008242A (fr)
EP (1) EP0804187A1 (fr)
JP (1) JPH10512270A (fr)
KR (1) KR19980701547A (fr)
CN (1) CN1168099A (fr)
AU (1) AU4328996A (fr)
BR (1) BR9606925A (fr)
CA (1) CA2208837A1 (fr)
CZ (1) CZ211997A3 (fr)
HU (1) HUP9800334A3 (fr)
IL (1) IL116826A (fr)
NO (1) NO973340L (fr)
TW (1) TW448046B (fr)
WO (1) WO1996022092A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
WO1999002152A1 (fr) * 1997-07-10 1999-01-21 Novo Nordisk A/S Utilisation de 3,4-diphenylchromanes pour la preparation d'une composition pharmaceutique permettant d'augmenter l'insulinosensitivite
EP1028724A1 (fr) * 1997-11-10 2000-08-23 Novo Nordisk A/S Administration transdermique de 3,4-diarylchromanes
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CA2581316C (fr) 2004-09-21 2013-09-10 Novogen Research Pty Ltd Derives de chromane substitues, medicaments et utilisation a des fins therapeutiques
EP2635273B1 (fr) 2010-11-01 2020-01-08 MEI Pharma, Inc. Compositions d'isoflavonoïdes et méthodes de traitement du cancer
MX368063B (es) 2014-02-07 2019-09-18 Novogen ltd Compuestos de benzopirano funcionalizados y uso de los mismos.
CN116139125A (zh) 2015-02-02 2023-05-23 梅制药公司 联合治疗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822287A (en) * 1969-04-17 1974-07-02 Rexall Drug Chemical Process for preparation of substituted 3,4-(diphenyl)chromans
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
EP0804187A1 (fr) 1997-11-05
HUP9800334A2 (hu) 1998-12-28
BR9606925A (pt) 1997-11-11
CN1168099A (zh) 1997-12-17
HUP9800334A3 (en) 1999-12-28
CA2208837A1 (fr) 1996-07-25
TW448046B (en) 2001-08-01
WO1996022092A1 (fr) 1996-07-25
NO973340D0 (no) 1997-07-18
MX9705378A (es) 1997-10-31
KR19980701547A (ko) 1998-05-15
AU4328996A (en) 1996-08-07
CZ211997A3 (en) 1997-12-17
NO973340L (no) 1997-07-18
IL116826A0 (en) 1996-05-14
US6008242A (en) 1999-12-28
JPH10512270A (ja) 1998-11-24

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL121170A0 (en) Compositions for the treatment of dermatological disorders
AU6406996A (en) Compositions for the treatment and diagnosis of body weight disorders, including obesity
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
HUP9603607A3 (en) Use of triazolidine derivatives for the preparation of pharmaceutical compositions for the treatment and prophylaxis of osteoporosis
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
IL117656A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
HUP9902683A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
IL116826A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity
IL117655A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
EP0852503A4 (fr) Composition pour le traitement de la diarrhee, son utilisation et sa preparation
IL116747A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment of gynaecomastia
AU5627796A (en) Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury
IL116827A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis
IL120005A (en) Pharmaceutical compositions for the treatment of the eye
GB9510162D0 (en) Compositions for the treatment of skin conditions
ZA96446B (en) Use of 3,4-diphenyl chromans for the manufacture of pharmaceutical composition for the treatment or prophylaxis of obesity
ZA96440B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ZA96248B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia

Legal Events

Date Code Title Description
FF Patent granted